184 related articles for article (PubMed ID: 21107986)
1. Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.
Mohtat D; Thomas R; Du Z; Boakye Y; Moulton T; Driscoll C; Woroniecki R
Pediatr Nephrol; 2011 Feb; 26(2):275-80. PubMed ID: 21107986
[TBL] [Abstract][Full Text] [Related]
2. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for early detection of sickle nephropathy.
Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance.
McIlroy DR; Wagener G; Lee HT
Clin J Am Soc Nephrol; 2010 Feb; 5(2):211-9. PubMed ID: 20056755
[TBL] [Abstract][Full Text] [Related]
5. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
[TBL] [Abstract][Full Text] [Related]
6. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
7. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus.
Yang CC; Hsieh SC; Li KJ; Wu CH; Lu MC; Tsai CY; Yu CL
J Biomed Biotechnol; 2012; 2012():759313. PubMed ID: 22500106
[TBL] [Abstract][Full Text] [Related]
8. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
Damman K; van Veldhuisen DJ; Navis G; Voors AA; Hillege HL
Eur J Heart Fail; 2008 Oct; 10(10):997-1000. PubMed ID: 18804416
[TBL] [Abstract][Full Text] [Related]
9. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
10. Urinary interleukin-18 and urinary neutrophil gelatinase-associated lipocalin predict acute kidney injury following pulmonary valve replacement prior to serum creatinine.
Buelow MW; Dall A; Regner K; Weinberg C; Bartz PJ; Sowinski J; Rudd N; Katzmark L; Tweddell JS; Earing MG
Congenit Heart Dis; 2012; 7(5):441-7. PubMed ID: 22537138
[TBL] [Abstract][Full Text] [Related]
11. Urinary neutrophil gelatinase associated lipocalin as a biomarker in ifosfamide induced chronic renal failure.
Kesik V; Demirkaya E; Buyukpamukçu M
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4851-7. PubMed ID: 26744877
[TBL] [Abstract][Full Text] [Related]
12. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
13. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients?
Hryniewiecka E; Gala K; Krawczyk M; Pączek L
Transplant Proc; 2014 Oct; 46(8):2782-5. PubMed ID: 25380917
[TBL] [Abstract][Full Text] [Related]
14. Urinary cystatin C and NGAL as early biomarkers for assessment of renal ischemia-reperfusion injury: a serum marker to replace creatinine?
Woodson BW; Wang L; Mandava S; Lee BR
J Endourol; 2013 Dec; 27(12):1510-5. PubMed ID: 24266750
[TBL] [Abstract][Full Text] [Related]
15. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.
Schinstock CA; Semret MH; Wagner SJ; Borland TM; Bryant SC; Kashani KB; Larson TS; Lieske JC
Nephrol Dial Transplant; 2013 May; 28(5):1175-85. PubMed ID: 22529161
[TBL] [Abstract][Full Text] [Related]
16. [Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology].
Bolignano D
G Ital Nefrol; 2010; 27(1):6. PubMed ID: 20191452
[No Abstract] [Full Text] [Related]
17. Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis.
Wu Y; Su T; Yang L; Zhu SN; Li XM
Am J Med Sci; 2010 Jun; 339(6):537-42. PubMed ID: 20545012
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery.
Wagener G; Gubitosa G; Wang S; Borregaard N; Kim M; Lee HT
Am J Kidney Dis; 2008 Sep; 52(3):425-33. PubMed ID: 18649981
[TBL] [Abstract][Full Text] [Related]
19. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation.
Wagener G; Minhaz M; Mattis FA; Kim M; Emond JC; Lee HT
Nephrol Dial Transplant; 2011 May; 26(5):1717-23. PubMed ID: 21257679
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
